Portland, OR: Nearly nine out of ten patients with epilepsy report using cannabis for therapeutic purposes, according to survey data published in the journal Epilepsy & Behavior.
Investigators from the Oregon Health and Science University surveyed epilepsy patients undergoing observation at a local hospital. Eighty-seven percent of respondents reported having consumed cannabis for symptom management, and 82 percent agreed that it mitigated seizure frequency. Most participants reported using cannabis products more dominant in CBD than THC. The majority of respondents reported inhaling herbal formulations of cannabis.
Last year, the US Food and Drug Administration and the Drug Enforcement Administration approved Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), for the treatment of severe forms of pediatric epilepsy.
For more information, contact Paul Armentano, NORML Deputy Director. Full text of the study, "Marijuana use by patients with epilepsy at a tertiary care center," appears in Epilepsy & Behavior.